People · Operator
Named in public records as an officer, director or promoter · active 2017–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Mesa Biotech, Inc. | — | Biotechnology | Series A | $19.8M | $108.5M | 2017 |
R. Bruce Cary at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside R. Bruce Cary on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Hong Cai | 1 | 1 |
| Tom Bruce Willardson | 1 | 1 |
| William Bruce Brody | 1 | 1 |
| Robert Bruce Cary | 1 | 1 |
| Eric Bruce Sagerman | 1 | 1 |
| Wen Bruce Chen | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.